Top compounds associated with response to ADGRF5


Feature Type Standardized
Nominal ANOVA
mRNA Irinotecan gCSI pan-cancer AAC -0.031 0.6
mRNA lapatinib gCSI pan-cancer AAC 0.019 0.7
mRNA paclitaxel gCSI pan-cancer AAC -0.014 0.8
mRNA MS-275 gCSI pan-cancer AAC 0.011 0.9
mRNA Bortezomib gCSI pan-cancer AAC -0.0055 0.9
mRNA Docetaxel gCSI pan-cancer AAC -0.0027 1
Download CSV